Chen Yu-Chia, Chang Jan-Gowth, Jong Yuh-Jyh, Liu Ting-Yuan, Yuo Chung-Yee
Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Epigenome Research Center, China Medical University Hospital, Taichung, Taiwan; Department of Laboratory Medicine, China Medical University Hospital, Taichung, Taiwan; School of Medicine, China Medical University, Taichung, Taiwan.
PLoS One. 2015 Mar 17;10(3):e0120721. doi: 10.1371/journal.pone.0120721. eCollection 2015.
Spinal muscular atrophy (SMA) is an inherited neuromuscular disease caused by deletion or mutation of SMN1 gene. All SMA patients carry a nearly identical SMN2 gene, which produces low level of SMN protein due to mRNA exon 7 exclusion. Previously, we found that the testis of SMA mice (smn-/- SMN2) expresses high level of SMN2 full-length mRNA, indicating a testis-specific mechanism for SMN2 exon 7 inclusion. To elucidate the underlying mechanism, we established primary cultures of testis cells from SMA mice and analyzed them for SMN2 exon 7 splicing. We found that primary testis cells after a 2-hour culture still expressed high level of SMN2 full-length mRNA, but the level decreased after longer cultures. We then compared the protein levels of relevant splicing factors, and found that the level of Tra2-β1 also decreased during testis cell culture, correlated with SMN2 full-length mRNA downregulation. In addition, the testis of SMA mice expressed the highest level of Tra2-β1 among the many tissues examined. Furthermore, overexpression of Tra2-β1, but not ASF/SF2, increased SMN2 minigene exon 7 inclusion in primary testis cells and spinal cord neurons, whereas knockdown of Tra2-β1 decreased SMN2 exon 7 inclusion in primary testis cells of SMA mice. Therefore, our results indicate that high expression level of Tra2-β1 is responsible for increased SMN2 exon 7 inclusion in the testis of SMA mice. This study also suggests that the expression level of Tra2-β1 may be a modifying factor of SMA disease and a potential target for SMA treatment.
脊髓性肌萎缩症(SMA)是一种由SMN1基因缺失或突变引起的遗传性神经肌肉疾病。所有SMA患者都携带几乎相同的SMN2基因,由于mRNA外显子7的排除,该基因产生的SMN蛋白水平较低。此前,我们发现SMA小鼠(smn-/- SMN2)的睾丸表达高水平的SMN2全长mRNA,这表明存在一种睾丸特异性机制促进SMN2外显子7的包含。为了阐明其潜在机制,我们建立了来自SMA小鼠的睾丸细胞原代培养物,并分析了它们的SMN2外显子7剪接情况。我们发现,培养2小时后的睾丸原代细胞仍表达高水平的SMN2全长mRNA,但培养时间延长后该水平下降。然后我们比较了相关剪接因子的蛋白水平,发现睾丸细胞培养过程中Tra2-β1的水平也下降,这与SMN2全长mRNA的下调相关。此外,在许多检测的组织中,SMA小鼠的睾丸中Tra2-β1的表达水平最高。此外,Tra2-β1的过表达而非ASF/SF2的过表达增加了原代睾丸细胞和脊髓神经元中SMN2小基因外显子7的包含,而敲低Tra2-β1则降低了SMA小鼠原代睾丸细胞中SMN2外显子7的包含。因此,我们的结果表明,Tra2-β1的高表达水平导致了SMA小鼠睾丸中SMN2外显子7包含的增加。这项研究还表明,Tra2-β1的表达水平可能是SMA疾病的一个修饰因子和SMA治疗的一个潜在靶点。